Sandpaper curettage: A simple method to improve PDT outcomes for actinic keratosis

Photodiagnosis Photodyn Ther. 2022 Dec:40:103050. doi: 10.1016/j.pdpdt.2022.103050. Epub 2022 Aug 3.

Abstract

Introduction: Photodynamic therapy (PDT) is a non-scarring, repeatable, and safe treatment for actinic keratosis (AK), but improvements in efficacy are still needed.

Background: Devices such as steel blades, needle rollers, and lasers are currently used to remove hypertrophic stratum corneum on AKs to improve PDT outcomes. However, curettage with fine sandpaper could be a gentler, effective alternative.

Methods: A retrospective study was designed to compare PDT with or without sandpaper curettage. Patients were selected from a database registry of patients with face and scalp AKs (ClinicalTrials.gov NCT03319251). Patients in Group 1 underwent PDT alone (20% ALA, 15 min; blue light 417 nm, 30 min). Patients in Group 2 were pretreated with gentle sandpaper curettage prior to ALA and illumination. The two groups were compared using multivariate matching, normalizing for age, sex, initial AK counts, and time to follow-up.

Results: Sixty-six patients were selected for matching analysis (n=38, PDT only; n=28, PDT+curettage). Demographics between the groups were similar (mean ± SD), including age (71.0 ± 8.3 vs. 71.0 ± 8.0 years), baseline AK count (53 ± 39 vs. 44± 32), and time to post-PDT follow-up (111 ± 28 vs. 113 ± 32 days). At follow-up, patients who received curettage showed an overall 55% improvement in scalp AK clearance compared to patients who did not receive curettage, adjusting for sex, age, time to follow-up, and baseline AK count (p = 0.0322, multivariable linear regression).

Discussion: Sandpaper curettage before PDT treatment is an easy and inexpensive method to significantly improve AK clearance rates.

Keywords: Actinic keratosis; Curettage; Photodynamic therapy; Sandpaper curettage.

MeSH terms

  • Aged
  • Aminolevulinic Acid / therapeutic use
  • Clinical Studies as Topic
  • Female
  • Humans
  • Keratosis, Actinic* / drug therapy
  • Male
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Aminolevulinic Acid
  • Photosensitizing Agents

Associated data

  • ClinicalTrials.gov/NCT03319251